Skip to main content

Azenta Value Stock - Dividend - Research Selection

Brooks automation

ISIN: US1143401024 , WKN: 257275

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Brooks Automation, Inc. provides automation and cryogenic solutions for various applications and markets. It operates in two segments, Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum, and contamination controls solutions and services. Its products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments; automated cleaning and inspection systems for wafer carriers, as well as reticle pod cleaners and stockers; and vacuum pumping and thermal management solutions for critical process vacuum applications. This segment also offers repair, diagnostic, and installation services, as well as spare parts and productivity enhancement upgrade services. The Brooks Life Science Systems segment provides automated cold storage systems; consumables, including various formats of racks, tubes, caps, plates, and foils; and instruments used for labeling, bar coding, capping, decapping, auditing, sealing, peeling, and piercing tubes and plates. It also provides sample management services, such as on-site and off-site sample storage, cold chain logistics, sample relocation, bio-processing, disaster recovery, and business continuity, as well as project management and consulting. In addition, this segment offers sample intelligence software solutions and customer technology integration; and laboratory work flow scheduling for life science tools and instrument work cells, sample inventory and logistics, environmental and temperature monitoring, and clinical trial and consent management, as well as planning, data management, virtualization, and visualization services. The company serves semiconductor capital equipment and sample management markets for life sciences in approximately 50 countries. Brooks Automation, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Undervalued Small Caps With Notable Insider Buying Activity

2026-05-28
Over the last 7 days, the United States market has risen by 1.3%, contributing to a notable 28% climb over the past year, with earnings expected to grow by 17% annually. In this context of robust market performance, identifying stocks that are both undervalued and have significant insider buying can be an effective strategy for investors seeking opportunities in small-cap companies.

Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks

2026-05-21
Looking back on drug development inputs & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Azenta (NASDAQ:AZTA) and its peers.

Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report

2026-05-21
Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued progress against its key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2025.

1 Russell 2000 Stock Worth Your Attention and 2 We Question

2026-05-17
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions

2026-05-16
Azenta’s first quarter was marked by operational challenges and a more cautious demand environment, which contributed to results well below market expectations. CEO John Marotta acknowledged, “We are not satisfied with our second quarter results,” citing both internal execution gaps and continued customer spending constraints, especially in North America. Management attributed the revenue shortfall largely to softer demand across Multiomics, competitive pressures, and delays in capital equipment

Earnings High Fliers And Busts

2026-05-14
More than 1,500 stocks have reported earnings since the current season began, and the average stock that's reported has seen an average absolute one-day share price reaction of roughly 7%.

Azenta, Inc. Q2 2026 Earnings Call Summary

2026-05-06
Moby summary of Azenta, Inc.'s Q2 2026 earnings call

Needham Maintains Buy on Azenta, Lowers Price Target to $33

2026-05-06
Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $44 to $33.

Azenta Q2 Earnings Call Highlights

2026-05-06
Azenta (NASDAQ:AZTA) reported fiscal second-quarter 2026 results that management said fell short of expectations, citing execution shortfalls and a cautious demand environment—particularly in North America—along with ongoing weakness in capital equipment spending. “Candidly, we are not satisfied wi

Azenta, Inc. (AZTA) Q2 2026 Earnings Call Transcript

2026-05-06
Azenta, Inc. (AZTA) Q2 2026 Earnings Call May 6, 2026 8:30 AM EDTCompany ParticipantsYvonne Perron - Vice President of Financial Planning & Analysis and...